Safety, immunogenicity and preliminary efficacy of multiple-site vaccination with an Epidermal Growth Factor (EGF) based cancer vaccine in advanced non small cell lung cancer (NSCLC) patients

Article

Abstract: The prognosis of patients with advanced non small cell lung (NSCLC) cancer remains dismal. Epidermal

Palabras claves:

Autores:

Carmen Elena Viada, García Verdecia B., González G., Lage Davila A., Luaces P.L.o., Montero E., Neninger Vinageras E., Popa X., Rodríguez P.C., Tania Crombet

Fuentes:

scopus